Through the NIH’s iPSC Neurodegenerative Disease Initiative (iNDI), we obtained 3 CRISPR-edited, homozygous mutant lines, α-syn A53T, TDP-43 Q331K, and tau N279K, as well as their parent isogenic WT iPSC line [34]. This evidence concerns the gene MAPT and glycogen storage disease VI.